Clinical Trial of Trametes Versicolor in Women With Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Coriolus versicolor extract

Trametes versicolor (Tv) capsules at the assigned dose level (3 grams/day up to 24 grams/day) twice a day every day and continuing for weeks.

Trial Locations (2)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

Unknown

Bastyr University, Kenmore

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT00680667 - Clinical Trial of Trametes Versicolor in Women With Breast Cancer | Biotech Hunter | Biotech Hunter